Summary
In this episode of Rosman Radio, Rob Nichols interviews Eric Mayer, CEO of New Day Diagnostics, a company focused on making cancer screening more accessible and convenient. They discuss the company’s journey from research and development to commercialization, the challenges of marketing in a regulated industry, and the importance of direct-to-consumer strategies. Eric shares insights on navigating regulatory landscapes, scaling the business, and the future of cancer diagnostics, including plans for international expansion and innovations in testing.
Takeaways
• New Day Diagnostics aims to democratize cancer testing.
• The company has a lean team focused on innovation.
• Direct-to-patient marketing is a key strategy.
• Regulatory challenges are significant in the medical field.
• Creating urgency for screenings is crucial for awareness.
• User experience is vital for patient engagement.
• The company is expanding into international markets.
• Continuous improvement in testing methods is a priority.
• The rise of at-home testing reflects changing patient needs.
• Cancer awareness is increasing, especially among younger demographics.